Sponsor Pipeline

Skyhawk Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
3
Phase 3
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-24 NCT07537075
An Extension of SKY-0515 in Participants With Huntington's Disease		 Trial sites expanded: 4 -> 10 locations
Active Trials by Phase
Phase 2/3
3
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07378644 Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants… Huntington Disease Recruiting
NCT06873334 Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With… Huntington Disease Active, Not Recruiting
NCT07537075 An Extension of SKY-0515 in Participants With Huntington's Disease Huntington's Disease (HD) Enrolling by Invitation
Disease Areas
Huntington's Disease (3)
Get alerts when Skyhawk Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free